Pandey, S.K.; Machlof-Cohen, R.; Santhanam, M.; Shteinfer-Kuzmine, A.; Shoshan-Barmatz, V.
Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules 2022, 12, 895.
https://doi.org/10.3390/biom12070895
AMA Style
Pandey SK, Machlof-Cohen R, Santhanam M, Shteinfer-Kuzmine A, Shoshan-Barmatz V.
Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules. 2022; 12(7):895.
https://doi.org/10.3390/biom12070895
Chicago/Turabian Style
Pandey, Swaroop Kumar, Renen Machlof-Cohen, Manikandan Santhanam, Anna Shteinfer-Kuzmine, and Varda Shoshan-Barmatz.
2022. "Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks" Biomolecules 12, no. 7: 895.
https://doi.org/10.3390/biom12070895
APA Style
Pandey, S. K., Machlof-Cohen, R., Santhanam, M., Shteinfer-Kuzmine, A., & Shoshan-Barmatz, V.
(2022). Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules, 12(7), 895.
https://doi.org/10.3390/biom12070895